Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:13:46 EDT Thu 19 Sep 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:ONC - ONCOLYTICS BIOTECH INC. - http://www.oncolyticsbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONC - T  0.51.29·1.320.31.28    3.10  1.20Sep 18Aug 0115 min RT 2¢
TSX - T0.51.29·1.320.31.28    3.10  1.20Sep 1815 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-08-01 17:14C:ONC1.48SEDAR Interim MD & ASEDAR Interim MD & A
2024-08-01 17:07C:ONC1.48SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-12 16:38C:ONC1.44SEDAR Preliminary Short Form ProspectusSEDAR Preliminary Short Form Prospectus
2024-07-12 11:05C:ONC1.44SEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-05-16 11:58C:ONC1.55News ReleaseOncolytics shareholders elect eight directors at AGM
2024-05-09 16:55C:ONC1.69SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-05-09 16:55C:ONC1.69SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-05 07:12C:ONC1.56In the NewsGlobe says Oncolytics Biotech kept at "outperformer"
2024-03-12 16:33C:ONC1.43SEDAR Annual ReportSEDAR Annual Report
2024-03-07 19:18C:ONC1.41SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-07 19:18C:ONC1.41SEDAR MD & ASEDAR MD & A
2024-03-07 16:22C:ONC1.41News ReleaseOncolytics spends $17.7-million on R&D in 2023
2024-03-05 10:34C:ONC1.37News ReleaseOncolytics files amendment to Goblet phase 1/2 study
2024-03-04 10:48C:ONC1.51News ReleaseOncolytics Biotech to release 2023 results March 7
2024-02-14 11:37C:ONC1.41News ReleaseOncolytics expands Goblet anal cancer study enrolment
2024-01-09 10:31C:ONC1.81News ReleaseOncolytics Biotech appoints Andrews as director
2024-01-04 09:40C:ONC1.76News ReleaseOncolytics Biotech recaps 2023 operations
2023-12-07 10:16C:ONC1.91News ReleaseOncolytics presents AWARE-1 data at cancer symposium
2023-11-09 10:43C:ONC1.82News ReleaseOncolytics presents Goblet results at IMACC in Rome
2023-11-09 10:03C:ONC2.15News ReleaseOncolytics plans to start phase 3 PDAC study mid-2024